| Name | ATP synthase membrane subunit k |
| Description | Predicted to be involved in proton motive force-driven ATP synthesis. Located in mitochondrion. Part of proton-transporting ATP synthase complex. Implicated in mitochondrial complex V (ATP synthase) deficiency nuclear type 6. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n ATP5MK, also known as DAPIT and encoded by the USMG5 gene, is a small, highly conserved subunit of the mitochondrial F‐ATP synthase complex that is critical for the assembly, stability, and dimerization of the enzyme. Its proper incorporation into ATP synthase is essential for maintaining adequate ATP production, and alterations in ATP5MK levels can markedly influence mitochondrial respiration and cellular energy metabolism."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In cell models, suppression or knockdown of ATP5MK results in the loss of the ATP synthase population within mitochondria, decreased ATP synthesis, and associated impairments in cell growth and survival, particularly under conditions of metabolic stress."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}, {"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Conversely, over‐expression of ATP5MK has been reported to disturb mitochondrial homeostasis by reducing mitochondrial mass and altering proton gradient balance, which contributes to a shift toward anaerobic metabolism and even promotes phenotypic changes such as epithelial-to-mesenchymal transition."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In pathological contexts, ATP5MK plays an adaptive or protective role; for instance, in diabetic nephropathy and heart failure models, its regulated expression is associated with a reduction in fibrosis and improved cardiac function, highlighting its importance in energy maintenance under stress."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Moreover, genetic disruption of ATP5MK has been linked to severe clinical syndromes such as Leigh syndrome, where compromised ATP synthase dimerization leads to impaired ATP production and devastating neurological outcomes"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": ", and alterations in its expression may also contribute to neuropsychiatric conditions like schizophrenia."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Finally, emerging evidence in muscular dystrophy models indicates that ATP5MK is part of a regulatory cascade modulated by microRNAs and translational factors that ultimately governs mitochondrial ATP synthesis, suggesting that modulation of ATP5MK may be therapeutically relevant in conditions of muscle degeneration."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Shigenori Ohsakaya, Makoto Fujikawa, Toru Hisabori, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Knockdown of DAPIT (diabetes-associated protein in insulin-sensitive tissue) results in loss of ATP synthase in mitochondria."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.198523"}], "href": "https://doi.org/10.1074/jbc.M110.198523"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21345788"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21345788"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "H Kontro, J J Hulmi, P Rahkila, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cellular and tissue expression of DAPIT, a phylogenetically conserved peptide."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Histochem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4081/ejh.2012.18"}], "href": "https://doi.org/10.4081/ejh.2012.18"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22688299"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22688299"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Heidi Kontro, Giuseppe Cannino, Pierre Rustin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "DAPIT Over-Expression Modulates Glucose Metabolism and Cell Behaviour in HEK293T Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0131990"}], "href": "https://doi.org/10.1371/journal.pone.0131990"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26161955"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26161955"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yoji Nagata, Masakazu Yamagishi, Tetsuo Konno, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heat Failure Phenotypes Induced by Knockdown of DAPIT in Zebrafish: A New Insight into Mechanism of Dilated Cardiomyopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-17572-y"}], "href": "https://doi.org/10.1038/s41598-017-17572-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29234032"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29234032"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Ruming Chen, Michael J Runswick, Joe Carroll, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of two proteolipids of unknown function with ATP synthase from bovine heart mitochondria."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2007.05.079"}], "href": "https://doi.org/10.1016/j.febslet.2007.05.079"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17570365"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17570365"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Emanuele Barca, Rebecca D Ganetzky, Prasanth Potluri, et al. "}, {"type": "b", "children": [{"type": "t", "text": "USMG5 Ashkenazi Jewish founder mutation impairs mitochondrial complex V dimerization and ATP synthesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddy231"}], "href": "https://doi.org/10.1093/hmg/ddy231"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29917077"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29917077"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Dongjun Dai, Rongkai Shi, Shuting Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Medicine (Baltimore) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MD.0000000000021478"}], "href": "https://doi.org/10.1097/MD.0000000000021478"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32769881"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32769881"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Zhongju Wang, Yongchang Zhu, Linyan Ye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation by CNNM2 of ATP5MD expression in the 10q24.32 schizophrenia-associated locus involved in impaired ATP production and neurodevelopment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "NPJ Schizophr (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41537-021-00159-y"}], "href": "https://doi.org/10.1038/s41537-021-00159-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34021155"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34021155"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ai Vu Hong, Mathilde Sanson, Isabelle Richard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Transl Myol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4081/ejtm.2021.10012"}], "href": "https://doi.org/10.4081/ejtm.2021.10012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34533019"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34533019"}]}]}]}
|
| NCBI Gene ID | 84833 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
ATP5MK has 1,434 functional associations with biological entities spanning 5 categories (disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 34 datasets.
Click the + buttons to view associations for ATP5MK from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ATP5MK gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with ATP5MK protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with ATP5MK gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with ATP5MK gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of ATP5MK gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing ATP5MK protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with ATP5MK protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by ATP5MK gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with ATP5MK gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving ATP5MK gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving ATP5MK gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing ATP5MK protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing ATP5MK protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of ATP5MK gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of ATP5MK gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with ATP5MK gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by ATP5MK gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of ATP5MK gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of ATP5MK gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by ATP5MK gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of ATP5MK gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving ATP5MK protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| Reactome Pathways 2024 | pathways involving ATP5MK protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of ATP5MK gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of ATP5MK gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of ATP5MK gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of ATP5MK gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of ATP5MK gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of ATP5MK gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of ATP5MK gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of ATP5MK gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of ATP5MK protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of ATP5MK protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with ATP5MK protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |